About 200 reports

These agents can provide pain relief, but do not slow disease progression or treat major inflammation.

  • Targeted Therapy
  • World
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Many of these are long-acting drugs that do not provide immediate pain relief but instead take effect over the course of a number of weeks or months and are administered regularly over a long-term period.

  • Targeted Therapy
  • World
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.

They provide rapid pain relief but do not slow disease progression or treat major inflammation.

  • Targeted Therapy
  • World
  • AbbVie Inc.
  • Galapagos NV
  • Pfizer Inc.

They provide rapid pain relief but do not slow disease progression or treat major inflammation.

  • Targeted Therapy
  • Southeast Asia
  • World
  • Market Size
  • Galapagos NV

Radiotherapy (RT) is also used to provide effective bone pain relief, with a Cochrane meta-analysis of ## trials finding that ##% of patients can expect to gain a ##% reduction in pain (McQuay et al., 2000).

  • Targeted Therapy
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

Many of these are long-acting drugs that do not provide immediate pain relief but instead take effect over the course of a number of weeks or months and are administered regularly over a long-term period as a maintenance therapy.

  • Targeted Therapy
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

Prostate cancer: palliative care and pain relief.

  • Targeted Therapy
  • World
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Pfizer Inc.

Many of these are long-acting drugs that do not provide immediate pain relief but instead take effect over the course of a number of weeks or months and are administered regularly over a long-term period.

  • Targeted Therapy
  • World
  • Market Size
  • Amgen Inc.
  • Biologics, Inc.

AES ASSOCIATED WITH THE ##MG DOSE WERE CHEST PAIN (N = ##), INFLUENZA, OUTER EAR INFECTION, AND SINUSITIS.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG

They are systemic, long-acting drugs which do not provide immediate pain relief but instead take effect over the course of a number of weeks or months and are administered regularly over a long-term period.

  • Targeted Therapy
  • World
  • Market Size
  • Johnson & Johnson
  • Novartis AG

The currently marketed branded products are either SC or IV, with the exception of Otezla, MTX, other generic systemic therapies, and add-on pain relief medicine.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

The currently marketed branded products are either SC or IV, with the exception of Otezla, MTX, other generic systemic therapies, and add-on pain relief medicine.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

The currently marketed branded products are either SC or IV, with the exception of Otezla, MTX, other generic systemic therapies, and add-on pain relief medicine.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

The currently marketed branded products are either SC or IV, with the exception of Otezla, MTX, other generic systemic therapies, and add-on pain relief medicine.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

RADIOTHERAPY IS ALSO USED TO PROVIDE EFFECTIVE BONE PAIN RELIEF, WITH A COCHRANE META-ANALYSIS OF ## TRIALS FINDING THAT ##% OF PATIENTS CAN EXPECT TO GAIN A ##% REDUCTION IN PAIN (MCQUAY ET AL., 2000).

  • Targeted Therapy
  • Demand
  • Market Size
  • AstraZeneca PLC
  • Pfizer Inc.

RADIOTHERAPY IS ALSO USED TO PROVIDE EFFECTIVE BONE PAIN RELIEF, WITH A COCHRANE META-ANALYSIS OF ## TRIALS FINDING THAT ##% OF PATIENTS CAN EXPECT TO GAIN A ##% REDUCTION IN PAIN (MCQUAY ET AL., 2000).

  • Targeted Therapy
  • World
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.

RADIOTHERAPY IS ALSO USED TO PROVIDE EFFECTIVE BONE PAIN RELIEF, WITH A COCHRANE META-ANALYSIS OF ## TRIALS FINDING THAT ##% OF PATIENTS CAN EXPECT TO GAIN A ##% REDUCTION IN PAIN (MCQUAY ET AL., 2000).

  • Targeted Therapy
  • World
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.

RADIOTHERAPY IS ALSO USED TO PROVIDE EFFECTIVE BONE PAIN RELIEF, WITH A COCHRANE META-ANALYSIS OF ## TRIALS FINDING THAT ##% OF PATIENTS CAN EXPECT TO GAIN A ##% REDUCTION IN PAIN (MCQUAY ET AL., 2000).

  • Targeted Therapy
  • World
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.

RADIOTHERAPY IS ALSO USED TO PROVIDE EFFECTIVE BONE PAIN RELIEF, WITH A COCHRANE META-ANALYSIS OF ## TRIALS FINDING THAT ##% OF PATIENTS CAN EXPECT TO GAIN A ##% REDUCTION IN PAIN (MCQUAY ET AL., 2000).

  • Targeted Therapy
  • World
  • Demand
  • Market Size
  • Novartis AG

The U. S. study enrolled ## adult patients with moderate-to-severe osteoarthritis of the hip or knee who had a history of inadequate pain relief or intolerance to acetaminophen, and at least one oral non steroidal anti-inflammatory drug (NSAID) and an opioid.

  • Chronic Pain
  • Targeted Therapy
  • World
  • Product Initiative
  • Pfizer Inc.
  • European Medicines Agency in writing of their intention within 15 days of receipt of the opinion.
  • CANAKINUMAB - DRUG PROFILE

Behcet Disease - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Behcet Disease - Pipeline Review, H2 2018, provides an overview of the Behcet Disease (Cardiovascular) pipeline landscape. "Behcet disease (BEH-chets), sometimes...

  • Targeted Therapy
  • Therapy
  • United States
  • Product Initiative
  • Celgene Corporation
  • Beta Nerve Growth Factor (Beta NGF or NGF) - Product Development Milestones

The U. S. study enrolled ## adult patients with moderate-to-severe osteoarthritis of the hip or knee who had a history of inadequate pain relief or intolerance to acetaminophen, and at least one oral nonsteroidal anti-inflammatory drug (NSAID) and an opioid.

  • Chronic Pain
  • Targeted Therapy
  • United States
  • World
  • Product Initiative

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases.

  • Allergy Drug
  • Targeted Therapy
  • Canada
  • United States
  • Product Initiative

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases.

  • Oncology
  • Targeted Therapy
  • World
  • Product Initiative
  • Amgen Inc.

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases.

  • Asthma
  • Biotech
  • Respiratory Disease
  • Targeted Therapy
  • AstraZeneca PLC

ALLOB treated patients will be assessed in comparison to baseline at ## weeks, ##, ## and ## months using clinical (e. g., pain, weight bearing) and radiological evaluation.

  • Targeted Therapy
  • United States
  • World
  • Product Initiative
  • Amgen Inc.

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Oncology
  • Targeted Therapy
  • United States
  • Product Initiative
  • Amgen Inc.
  • canakinumab - Drug Profile

ACZ## provided rapid and long-lasting symptom relief by targeting interleukin-## beta, a key inflammatory mediator of the disease. "

  • Monoclonal Antibody
  • Targeted Therapy
  • United States
  • Product Initiative
  • Novartis AG
  • PIPELINE BY GIGAGEN INC, H2 2018

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases.

  • Monoclonal Antibody
  • Targeted Therapy
  • United States
  • Product Initiative
  • MedImmune, LLC
  • CANAKINUMAB - DRUG PROFILE

AN ANALYSIS OF ESTEEM ## AND ## DEMONSTRATED THAT APREMILAST IMPROVED SKIN DISCOMFORT/ PAIN.

  • Targeted Therapy
  • Therapy
  • United States
  • Product Initiative
  • Celgene Corporation